In a repeat of a dynamic that dominated trading early last year, investors piled into stocks Thursday as Russia signed up for another cease-fire deal in Ukraine while negotiations between Greece and the European establishment suddenly became less acrimonious. While no deal has been announced, the bureaucrats have been making noises about agreeing to the outlines of an agreement which, […]
98 Up Last Year And 22 Winning Trades In A Row, Business / Investing
Select LanguageEnglishAfrikaansAlbanianArabicBelarusianBulgarianCatalanChinese (Simplified)Chinese (Traditional)CroatianCzechDanishDutchEstonianFilipinoFinnishFrenchGalicianGermanGreekHebrewHindiHungarianIcelandicIndonesianIrishItalianJapaneseKoreanLatvianLithuanianMacedonianMalayMalteseNorwegianPersianPolishPortugueseRomanianRussianSerbianSlovakSlovenianSpanishSwahiliSwedishThaiTurkishUkrainianVietnameseWelshYiddish
We have 56 guests online
Taken from:
98 Up Last Year And 22 Winning Trades In A Row, Business / Investing #Business #Investing
See which stocks are being affected by Social Media
[…]
A doubling of Gilead Sciences ‘ sales has given investors plenty of reason to cheer on the biotech Goliath over the past year. However, with Gilead Sciences’ sales growth set to slow this year, investors may find that these three top biotech stocks prove to be a better bet in 2015.Source: Biogen Idec: Gilead Sciences’ slowing sales growth this year […]
View photo.By and large, short interest among the leading biotechs and emerging pharmaceuticals dwindled between the January 15 and January 30 settlement dates.Leading that trend were Amgen, Inc. (NASDAQ: AMGN), Celgene Corporation (NASDAQ: CELG) and Vertex Pharmaceuticals Incorporated (NASDAQ: VRTX).Here we take a quick look at how these three stocks have fared recently and what analysts expect from them. That […]
CORAL GABLES, FL / ACCESSWIRE / February 11, 2015 / It’s been a long and rough road for a push toward universal legalization of marijuana in the US. Since the early beginnings in California many decades ago with medical marijuana to the latest trail being blazed from states like Colorado, Oregon, Washington, and Alaska, this has certainly become a growth […]
The bulls were large and in charge on Tuesday as investors ignored renewed weakness in crude oil and a worsening situation in Ukraine to bid stocks higher ahead of Wednesday’s big Eurogroup meeting at which Greece’s proposal to renegotiate its bailout program will be discussed.In the end, the Dow Jones Industrial Average gained 0.8%, the S&P 500 gained 1.1%, the […]
There may be no other industry as prone to hit-or-miss investments as biotechnology. An astounding 90% of drugs that enter phase 1 clinical trials never reach commercialization, and that means failure is far more common than success. As a result, many biotech companies research a slate of drugs in hopes of having at least one pan out. That’s not the […]
Source: Flickr user Simon & His Camera .Love is in the air. At least it is for three of our top Motley Fool healthcare contributors. Each has a crush on a different biotech stock darling, and they all find their pick attractive for different reasons. Read on to learn which biotech companies have caught the fancy of these three contributors, […]
See the article here –
Is this Wall Street's favorite new trade?
[…]
Some well-known biotechnology exchange traded funds could be stirred by Gilead Sciences (GILD) fourth-quarter earnings report released Tuesday after the close of U.S. markets.The California-based company posted net income of $3.49 billion, or $2.18 a share, compared with $791 million, or 47 cents a share, a year earlier as revenue more than doubled to $7.31 billion from $3.12 billion on […]
